Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

A woman developed male characteristics after using unregulated hormone therapy.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Hormonal therapy in adults with gender dysphoria often leads to skin issues like acne, requiring a team of skin and hormone doctors.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Eating disorders in gender dysphoria patients may be a coping mechanism for body image issues.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Women and men experience different quality of life and symptom distress after kidney transplant with immunosuppressive therapy.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

Testosterone therapy in transgender individuals can increase the risk of erythrocytosis.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Oral minoxidil can effectively treat hair loss in transgender and gender-diverse individuals.

Facial feminization surgery is safe and patients are satisfied, but more detailed research is needed.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Sublingual minoxidil significantly improves hair growth in transgender individuals on testosterone therapy.

Spironolactone and finasteride are equally effective for hirsutism in transgender women.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Feminizing hormone therapy increases hair counts and improves hair-related quality of life, while masculinizing therapy may reduce large terminal hairs.